Concepedia
Statistics
Publications
9
Citations
2.2K
H-Index
Active since
2000
Affiliations
Medway NHS Foundation Trust(Current)
Oxford University Hospitals NHS Trust
Roslin Institute
University of Bristol
Oxford University Clinical Research Unit
Andrew Low is an author at Medway NHS Foundation Trust specializing in pharmacotherapy, 28-day mortality, and primary outcome analysis.
Publications per year
2000–2024
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +6
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Artificial intelligence for sex determination of skeletal remains: Application of a deep learning artificial neural network to human skulls
James Bewes, Andrew Low, Antony Morphett et al. · Journal of Forensic and Legal Medicine · 2019 · 165 citations
Computing, Anatomy, Computer Science +17
1–5 of 9